DIVISION OF NEUROSCIENCE AND BEHAVIORAL RESEARCH (DNBR) NATIONAL ADVISORY COUNCIL ON DRUG ABUSE FEBRUARY 14, 2001 NIDA NATIONAL INSTITUTE ON DRUG ABUSE.

Slides:

Advertisements

Similar presentations

Research Training Programs at the NIH Marya Levintova, Ph.D. International Program Officer for Russia, Eurasia and Arctic Affairs Division of International.

Advertisements

Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia

55 Wade Avenue Catonsville, Maryland Committed to providing access to a quality and effective substance abuse.

What’s NIH? National Cancer Institute National Eye Institute National Heart, Lung, and Blood Inst. National Human Genome Research Inst National Institute.

Promoting Diversity and Science for Health Equity -- Introduction of NIDA Minority Diversity Programs Yu (Woody) Lin, M.D., Ph.D Program Director Division.

NIDA Director’s Report to the National Advisory Council on Drug Abuse National Advisory Council on Drug Abuse February 14, 2001.

Ending Veteran Homelessness in the Commonwealth of Virginia by the end of 2015.

Undergraduate and MSc courses in the Division of Biosciences Dr. Christian Rudolph

Translational Research in Tobacco Dependence Treatment Caryn Lerman, Ph.D. Deputy Director Abramson Cancer Center University of Pennsylvania.

Bioscience/Biomedical Research at Idaho State University Christopher Daniels, Ph.D. Director, ISU Biomedical Research Institute and Professor of Pharmaceutical.

Validity with Pragmatism Specific Issues in experimental design and implementation II-A.

NA shell NA shell vPFC mVP VTA NA core NA core dPFC SN dVP Blockade in these regions blocks relapse or reinstatement Drug Seeking Behavior – Motor Subcircuit.

What Do Toxicologists Do?

National Science Foundation Directorate for Biological Sciences Susan J. Lolle, Program Director Developmental Systems Cluster, Division of Integrative.

Career Development in Translational Addiction Research

Director’s Report to the National Advisory Council on Drug Abuse Director’s Report to the National Advisory Council on Drug Abuse May 22, 2003.

Office of Cellular Tissue and Gene Therapies Celia M.Witten, Ph.D., M.D. Director, Office of Cellular, Tissue, and Gene Therapies Cellular, Tissue, and.

Genetics & Addiction Jonathan D. Pollock, Ph.D. Division of Neuroscience & Behavioral Research National Institute on Drug Abuse National Institutes of.

Thinking of Studying Biological Sciences? Dr Amrit Mudher Lecturer in Neurosciences School of Biological Sciences University of Southampton

Introduction to the NIH Grants System

Director’s Report to the National Advisory Council on Drug Abuse Director’s Report to the National Advisory Council on Drug Abuse May 22, 2002 (Prepared.

A Doctoral Curriculum in Transition Shoumita Dasgupta, Ph.D. A Case Study of Boston University’s Graduate Medical Sciences Curriculum Reform.

Intramural Research Program (IRP) Report to NIDA Council May, 2006.

Director’s Report to the National Advisory Council on Drug Abuse Director’s Report to the National Advisory Council on Drug Abuse February 12, 2004.

Municipal Drug Policy Legislation, institutions and programs Assoc. Prof. Hristo Bozov, MD, PhD Deputy-Mayor of Municipality of Varna Chairman of Municipal.

 GPiBS (Graduate Program in Biomedical Sciences) is offered through the Graduate College at the University of Oklahoma Health Sciences Center.  All students.

Lis Nielsen, Ph.D. Division of Behavioral and Social Research (BSR) National Institute on Aging NIA/IPSR Workshop: Advancing Integrative.

NIH Roadmap for Medical Research and Common Fund Update on Recent Changes Dinah Singer, Ph.D. Director, Division of Cancer Biology June 18, 2008.

Overall Goal Support integrative research in organismal biology at the frontier.

Jacques Normand, Ph.D. Director, AIDS Research Program National Institute on Drug Abuse NIDA’s New HIV/AIDS Research Program.

Fogarty International Center: HIV Research Training Program: New Applications and Strategies Gene D. Morse, PharmD University at Buffalo AIDS International.

Public/Private Partnerships in Neuroscience and The George & Ann Ryan Neuroscience Institute.

Overview of NIDA Funding Opportunities and Grant Funding Tips Bethany Griffin Deeds, Ph.D., M.A. Deputy Chief, Epidemiology Research Branch Division of.

The Cancer Systems Biology Consortium (CSBC)

Pharmacology Science that studies interactions of drugs with organism on different levels (subcellular, cellular, organ, systemic) Studies: -relationship.

Introduction to Behavioral Pharmacology. Defining Behavioral Pharmacology Behavioral Pharmacology is a specialization of behavioral science that applies.

Update on the NIDA Intramural Program. We have recruited Dr. Elliot Stein as Chief, Neuroimaging Research Branch who is introducing fMRI into the existing.

 Students in 11 th Grade  Chemistry Class  Low mathematical skills  Do not see science as relevant  Difficulty grasping the microscopic (atomic)

Center for Scientific Review (CSR). Office of the Director National Institute on Alcohol Abuse and Alcoholism National Institute on Alcohol Abuse and.

An Overview of Peer Review at CSR – Critical Do’s and Don’ts Joy Gibson, D.Sc. Director, Division of Translational and Clinical Sciences American Association.

Tony G.Waldrop Vice Chancellor Research and Economic Development UNC-Chapel Hill and the NIH Roadmap NIH ROADMAP.

REPORT From the Basic Science Review Work Group National Institute on Drug Abuse May 2006 National Institute on Drug Abuse Division of Basic Neuroscience.

Location, mission, & overview of the curriculum …… J. Peter Gergen (Director, Undergraduate Biology) UNDERGRADUATE BIOLOGY at STONY BROOK UNIVERSITY.

NAS/IOM Review of Rare Diseases Research and Orphan Products Development - USA Timothy Cote, M.D., MPH Director, Office of Orphan Products Development.

Consortium for Interdisciplinary Studies on Science for Aging.

1 THE NIDA NATIONAL PREVENTION RESEARCH INITIATIVE NIDA Advisory Council February 20, 2002.

Group leader and participants Chronic Pain -Dr. Daniel Clauw Associate Dean for Clinical and Translational Research and Director, Chronic Pain and Fatigue.

NEUROSCIENCE AS AN INTEGRATED DISCIPLINE

Robert H. Wiltrout Director, CCR Director’s Address.

NIDA Intramural Research Program (IRP) Visited by NIDA Council in September 2004 Reviews by the Board of Scientific Councilors in February & September.

NIDA’s Research Training Program Update for: National Advisory Council on Drug Abuse September 21, 2005.

National Institutes of Health U.S. Department of Health and Human Services Recipe for an RFA (Request for Applications) Danielle J. Carlin, PhD, DABT Program.

Update from the Division of Epidemiology, Services and Prevention Research Wilson M. Compton, M.D., M.P.E. Director, Division of Epidemiology, Services.

Scottish Executive Environmental and Rural Affairs Department Strategic Science Advisory Panel Research-Base Priorities for Scotland Professor David Gani.

1 Modelling and Simulation EMBL – Beyond Molecular Biology Physics Computational Biology Chemistry Medicine.

Research Directions and Update from the NIA Basil Eldadah Division of Geriatrics and Clinical Gerontology NIA.

1 The Faculty of Medicine Name, title of the presentation.

National Health Strategy

ANALGESIC, ANESTHETIC, AND ADDICTION CLINICAL TRIAL TRANSLATIONS, INNOVATIONS, OPPORTUNITIES, AND NETWORKS (ACTTION) Public-Private Partnership WITH.

New Approaches to Metabolomics Research

Putting the brain in its place

Interdisciplinary research on language & speech

Interdisciplinary research on language & speech

U.P. Health Strategies May 8, 2018.

Making Science Relevant to Students Lives Teaching Module December 4, 2010 Frehiwot Gebrehiwot RET Fellow 2010 University of Illinois at Chicago.

Тархи ба оюун \Brain and Mind\

Approaches in psychology: Posters

Publishers of Quality Research

Cecil and Ida Green Distinguished Professor

National Institutes of Health

Presentation transcript:

DIVISION OF NEUROSCIENCE AND BEHAVIORAL RESEARCH (DNBR) NATIONAL ADVISORY COUNCIL ON DRUG ABUSE FEBRUARY 14, 2001 NIDA NATIONAL INSTITUTE ON DRUG ABUSE

Reorganization of DNBR WHY? NIDA NATIONAL INSTITUTE ON DRUG ABUSE

More efficiently identify the cause and consequence of substance abuse in order to improve treatment OVERALL: NIDA NATIONAL INSTITUTE ON DRUG ABUSE

Director: Dr. Glen Hanson Deputy Director for Program: Dr. David Shurtleff Deputy Director for Science and Technology Development: Dr. Karen Skinner Associate Director for Neuroscience Coordination: Dr. Roger Brown Special Assistant and Training Coordinator: Dr. Charles Sharp Deputy to Training Coordinator: Beth Babecki NIDA NATIONAL INSTITUTE ON DRUG ABUSE OFFICE OF DNBR DIRECTOR

Organized into 5 branches to reflect contemporary strategies and technologies Areas of interest assigned as they relate to basic science issues NIDA NATIONAL INSTITUTE ON DRUG ABUSE

Behavioral and Cognitive Science Research Branch Antecedent and consequent behavioral and cognitive factors to drug abuse, electro- physiological and systems processes and computational modeling NIDA NATIONAL INSTITUTE ON DRUG ABUSE Acting Chief: Dr. Minda Lynch Program Officers: Drs. Paul Schnur, Susan Volman & Cora Lee Wetherington

Chemistry and Physiological Systems Research Branch Analytical methods, basic chemistry, pharmacokinetics, perinatal effects, AIDS, neuroimmune function, and peripheral physiological systems NIDA NATIONAL INSTITUTE ON DRUG ABUSE Chief: Dr. Rao Rapaka Program Officers: Dr. Paul Hillary, Pushpa Thadani and Hari Singh

Pharmacology, Integrative and Cellular Neurobiology Research Branch Neuroendocrine modulation, cellular neuro- pharmacology, mechanisms of neurotrans- mission, neuropasticity, neurotoxicity and neuroprotection NIDA NATIONAL INSTITUTE ON DRUG ABUSE Acting Chief: Dr. Nancy Pilotte Program Officers: Drs. Jerry Frankenheim and Geraline Lin

Genetics and Molecular Neuro- biology Research Branch Genotypic and phenotypic factors, trans- criptional regulation, applied proteomics and basic cellular mechanisms NIDA NATIONAL INSTITUTE ON DRUG ABUSE Acting Chief: Dr. Jonathan Pollock Program Officers: Dr. Rebekah Rasooly, Two positions to be filled

Applied cognition, analgesic systems, neuroimaging, technology development, clinical application of basic science, cooperative interest with other divisions, institutes and private sector Translational Research Branch NIDA NATIONAL INSTITUTE ON DRUG ABUSE Special interest: nicotine-related issues, pain, and frontal lobe mechanisms

Translational Research Branch NIDA NATIONAL INSTITUTE ON DRUG ABUSE Acting Chief: Dr. David Thomas Program Officers: Drs. Thomas Aigner and Herb Weingartner

MAJOR OBJECTIVES: NIDA NATIONAL INSTITUTE ON DRUG ABUSE

Factors contributing to addiction transition NIDA NATIONAL INSTITUTE ON DRUG ABUSE Neural development and its role in vulnerability to addiction Genetics of vulnerability Basic cognitive & behavioral processes related to drug abuse Use of emerging technologies (e.g. gene arrays)to study the addiction Proteomics to appreciate the role of proteins in the addiction process Translation

INITIATIVES NIDA NATIONAL INSTITUTE ON DRUG ABUSE RFA initiatives -Insertional Mutagenesis -Cutting Edge -GHB Initiative - Computational Supplement - Transition to Addiction Anticipated initiatives - Cognition and Frontal Lobes in Addiction - Protein Trafficking and Drugs of Abuse - Nicotine Workgroup (Translational Model)

NIDA NATIONAL INSTITUTE ON DRUG ABUSE QUESTIONS?